<DOC>
	<DOCNO>NCT01513928</DOCNO>
	<brief_summary>This study design compare pharmacokinetics three different formulation Pf-04937319</brief_summary>
	<brief_title>A Study To Compare The Pharmacokinetics Of Different Formulations Of PF-04937319 In Healthy Subjects</brief_title>
	<detailed_description />
	<criteria>Healthy male and/or female subject age 21 55 year , inclusive . Healthy define clinically relevant abnormality identify detailed medical history , full physical examination , include blood pressure pulse rate measurement , 12lead ECG clinical laboratory test . Subjects childbearing potential must agree use highly effective method contraception throughout study least 28days last dose treatment . Body Mass Index ( BMI ) 23 33 kg/m2 total body weight &gt; =50 kg ( 110 lb ) . Evidence history clinically significant hematological , renal , endocrine , pulmonary , gastrointestinal , cardiovascular , hepatic , psychiatric , neurologic , allergic disease ( exclude untreated seasonal allergy ) . Any condition possibly affect drug absorption ( eg , gastrectomy ) . A positive urine drug screen .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>pharmacokinetics</keyword>
	<keyword>relative bioavailability</keyword>
	<keyword>formulation comparison</keyword>
</DOC>